Dong quai Alternatives Compared
Dong quai | Reblozyl (luspatercept) | Epoetin alfa |
|
---|
Dong quai | Reblozyl (luspatercept) | Epoetin alfa |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Used for Allergies, Anemia, Constipation - Chronic, Headache, Herbal Supplementation. Dong quai may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myelodysplastic Syndrome, Beta Thalassemia, Anemia. Reblozyl may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease, Anemia, Anemia - Chemotherapy Induced, Anemia - Drug Induced, Anemia Prior to Surgery. Epoetin alfa may also be used for purposes not listed in... View more |
Related suggestions |
|||||||
More about Dong quai | More about Reblozyl (luspatercept) | More about Epoetin alfa | ||||||||
Ratings & Reviews | ||||||||||
Dong quai has an average rating of 5.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
Reblozyl has an average rating of 9.2 out of 10 from a total of 6 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
Epoetin alfa has an average rating of 5.0 out of 10 from a total of 9 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Reblozyl side effects |
View all Epoetin alfa side effects |
|||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Reblozyl prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
N/A |
N/A |
Epogen, Procrit, Retacrit | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
168 hours |
264 hours |
19 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Unknown
CSA Schedule is unknown. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category N
Not classified
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 46 drugs are known to interact with Dong quai:
|
A total of 2 drugs are known to interact with Reblozyl:
|
A total of 21 drugs are known to interact with Epoetin alfa:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
First Approval Date | ||||||||||
N/A |
November 08, 2019 |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
||||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.